tirzepatide non responders Why GLP-1 Non-Responders Need Earlier Anti-Obesity Medication Intervention GlobalRPH Can tirzepatide be used off‑label

"The reason GLP-1 agonist medications are successful in treating diabetes and weight loss is because they promote delayed gastric emptying, early satiety and decreased appetite

This work has significant implications for understanding muscle preservation during fat loss

A new study used the Food and Drug Administrations adverse effects database over a 20-year period to see if there was an association between weight-loss drugs and MS (Shirani and colleagues

This suggests tirzepatide has direct anti-inflammatory effects that operate independently of its metabolic benefits, at least in the initial weeks of treatment